From 2020 to 2022, our initiatives stimulated an additional investment of 3.7 billion USD in NCDs – Martin Bernhardt

NCRI is winding down after 22 remarkable years

We encourage our European colleagues to build a strong clinical trials infrastructure so that we can have more patients offered clinical trials and we can get to answers sooner

Patients with loss of Y chromosome (LOY) had poorer prognosis when their bladders were removed, but somewhat paradoxically, better overall survival rates when they received immune checkpoint inhibitors

We are pleased to announce the formulation of the Asia Pacific Coalition Against Lung Cancer

We are pleased to announce the acquisition of Southland Radiation Oncology Network (SRON)

Dr. Ron Scheff has mentored and trained nearly 70 fellows – Christine Garcia

We lowered the price of the genome from about $5,000 to $200 allowing millions to benefit from genomics

Cancer Treatment in the Community! – Wee Joo Chng

We show, for the first time, that diabetes may interfere with the activity of immunotherapy – Ido Wolf